newsfilter
← Latest News
GlobeNewswire·

MannKind to Report First Quarter 2026 Financial Results on May 6, 2026

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD), a biopharmaceutical company dedicated to transforming chronic disease care through innovative,